脓毒症患者新发心房颤动的危险因素:系统评价与Meta分析
本系统评价与Meta分析检索Medline、Embase、Web of Science和Cochrane CENTRAL,评估脓毒症期间新发心房颤动的危险因素,提取校正比值比(OR)并对出现在一项以上研究中的因素进行合并。共检验44个可能危险因素,其中18个纳入Meta分析。危险因素包括人口学因素、合并症,而最强的为脓毒症相关因素;新发房颤几率变化超过50%的脓毒症相关因素包括糖皮质激素使用、右心导管、真菌感染、血管升压药使用和平均动脉压目标80-85 mmHg。多种已知的社区获得性房颤心血管危险因素在脓毒症新发房颤中未被识别为危险因素。作者认为结果可为房颤预防研究提供靶点,并对糖皮质激素给药、血管升压药选择和血压目标等脓毒症管理领域有启示。
要点
- 脓毒症新发房颤的最强危险因素为脓毒症相关因素,而非社区获得性房颤的经典心血管危险因素。
- 新发房颤几率变化超过50%的脓毒症相关因素包括:糖皮质激素使用、右心导管、真菌感染、血管升压药使用、平均动脉压目标80-85 mmHg。
- 多种已知的社区获得性房颤心血管危险因素在脓毒症新发房颤中未被识别为危险因素。
- 共检验44个可能危险因素,其中18个纳入Meta分析,效应量为校正OR。
- 作者认为结果对糖皮质激素给药、血管升压药选择和血压目标等脓毒症管理领域有启示。
适用人群与场景
- 脓毒症患者(系统评价与Meta分析纳入的研究人群)
研究设计与关键结果
- 研究类型为系统评价与Meta分析,检索Medline、Embase、Web of Science和Cochrane CENTRAL。
- 共检验44个脓毒症新发房颤的可能危险因素,其中18个纳入Meta分析,提取的效应量为校正比值比(OR)。
- 危险因素包括人口学因素、合并症,而最强的为脓毒症相关因素。
- 新发房颤几率变化超过50%的脓毒症相关因素包括:糖皮质激素使用、右心导管、真菌感染、血管升压药使用、平均动脉压目标80-85 mmHg。
- 多种已知的社区获得性房颤心血管危险因素在脓毒症新发房颤中未被识别为危险因素。
证据类型、等级与局限
- 证据类型:系统评价与Meta分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为结果可为未来聚焦房颤预防的研究提供靶点。
- 作者认为结果对脓毒症管理的若干关键领域有启示,包括糖皮质激素给药、血管升压药选择和血压目标。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: Atrial fibrillation frequently develops in patients with sepsis and is associated with increased morbidity and mortality. Unfortunately, risk factors for new-onset atrial fibrillation in sepsis have not been clearly elucidated. Clarification of the risk factors for atrial fibrillation during sepsis may improve our understanding of the mechanisms of arrhythmia development and help guide clinical practice.
DATA SOURCES: Medline, Embase, Web of Science, and Cochrane CENTRAL.
STUDY SELECTION: We conducted a systematic review and meta-analysis to identify risk factors for new-onset atrial fibrillation during sepsis.
DATA EXTRACTION: We extracted the adjusted odds ratio for each risk factor associated with new-onset atrial fibrillation during sepsis. For risk factors present in more than one study, we calculated pooled odds ratios (meta-analysis). We classified risk factors according to type and quantified the factor effect sizes. We then compared sepsis-associated atrial fibrillation risk factors with risk factors for community-associated atrial fibrillation.
DATA SYNTHESIS: Forty-four factors were examined as possible risk factors for new-onset atrial fibrillation in sepsis, 18 of which were included in meta-analyses. Risk factors for new-onset atrial fibrillation included demographic factors, comorbid conditions, and most strongly, sepsis-related factors. Sepsis-related factors with a greater than 50% change in odds of new-onset atrial fibrillation included corticosteroid use, right heart catheterization, fungal infection, vasopressor use, and a mean arterial pressure target of 80-85 mm Hg. Several cardiovascular conditions that are known risk factors for community-associated atrial fibrillation were not identified as risk factors for new-onset atrial fibrillation in sepsis.
CONCLUSIONS: Our study shows that risk factors for new-onset atrial fibrillation during sepsis are mainly factors that are associated with the acute sepsis event and are not synonymous with risk factors for community-associated atrial fibrillation. Our results provide targets for future studies focused on atrial fibrillation prevention and have implications for several key areas in the management of patients with sepsis such as glucocorticoid administration, vasopressor selection, and blood pressure targets.
参考来源
- Bosch NA, Cohen DM, Walkey AJ, et al. Risk Factors for New-Onset Atrial Fibrillation in Patients With Sepsis: A Systematic Review and Meta-Analysis. Crit Care Med. 2019. PMID: 30653473. doi:10.1097/CCM.0000000000003560
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。